ArticleFrontiers in cell and developmental biology2021

Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein.

Tianyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.